Diuretic Agents in Hypertension and other disorders

Slides:



Advertisements
Similar presentations
Diuretics Clinical Conditions Requiring Diuretic Therapy:
Advertisements

THIAZIDE DIURETICS Secreted into the tubular lumen by the organic acid transport mechanisms in the proximal tubule Act on the distal tubule to inhibit.
Diuretics. A. Kidney functions Kidneys have a number of essential functions:
Chapter 41 Diuretics 1.
Diuretics and Dehydrants. §1 Diuretics Abnormalities in fluid volume and electrolyte composition are common and important clinical problems. Drugs that.
DIURETICS. Functions of the kidneys Volume Acid-base balance Osmotic pressure Electrolyte concentration Excretion of metabolites and toxic substances.
Urinary System Spring 2010.
H + Homeostasis by the Kidney. H + Homeostasis Goal:  To maintain a plasma (ECF) pH of approximately 7.4 (equivalent to [H + ] = 40 nmol/L Action needed:
Diuretics A diuretic is a substance that increases the rate of urine volume output Most diuretics also increase urinary excretion of solutes, especially.
Diuretics. Why do we want to know about diuretics? What do kidneys do? What can go wrong? Interventions that can be used how do they work? Effects, side.
Excretion of Water and Electrolytes
BIMM118 Renal Pharmacology Diuretics: Carbonic Anhydrase Inhibitors Thiazides Loop Diuretics Potassium-sparing Diuretics.
Renal Structure and Function. Introduction Main function of kidney is excretion of waste products (urea, uric acid, creatinine, etc). Other excretory.
MCB 135E Discussion. MIDTERM II Review Monday the 7 th of November 2040 VLSB 6-8pm questions regarding exam well in advance.
DIURETICS Brogan Spencer and Laura Smitherman. What is a diuretic? Substance that promotes the formation (excretion) of urine.
Control of Renal Function. Learning Objectives Know the effects of aldosterone, angiotensin II and antidiuretic hormone on kidney function. Understand.
Transport Of Potassium in Kidney Presented By HUMA INAYAT.
Role of Kidneys In Regulation Of Potassium Levels In ECF
Diuretics Chris Hague, PhD
DIURETICS By: Prof. A. Alhaider.
DPT IPMR KMU Dr. Rida Shabbir.  K+ extracellular 4.2 mEq/L  Increase in conc to 3-4 mEq/L causes cardiac arrhythmias causing cardiac arrest and fibrilation.
Diuretics. From Knauf & Mutschler Klin. Wochenschr : % 20% 5% 4.5% 0.5% Volume 1.5 L/day Urine Na 100 mEq/L Na Excretion 155 mEq/day.
Lecture 4 Dr. Zahoor 1. We will discuss Reabsorption of - Glucose - Amino acid - Chloride - Urea - Potassium - Phosphate - Calcium - Magnesium (We have.
 Paired kidneys  A ureter for each kidney  Urinary bladder  Urethra 2.
Prof. Hanan Hagar Pharmacology Department
Diuretics Remove sodium & water
DIURETIC DRUGS.
1-Overview 2-Classification 3-Indiviual drugs 1-Indications of Diuretics. 2-Adverse effects. 3-Mannitol and Carbonic Anhydrase inhibitors.
Lecture – 3 Dr. Zahoor 1. TUBULAR REABSORPTION  All plasma constituents are filtered in the glomeruli except plasma protein.  After filtration, essential.
Diuretics the role of different portions of the nephron in ion exchange; the sites of action and pharmacology of diuretics; the therapeutic applications.
BLOCK: URIN 313 PHYSIOLOGY OF THE URINARY SYSTEM LECTURE 3 1 Dr. Amel Eassawi.
Renal tubular reabsorption/Secretion. Urine Formation Preview.
Diuretics Diuretics Heny Ekowati Pharmacy Departement Faculty of Medicine and Health Sciences.
CARBONIC ANHYDRASE INHIBITORS ACETAZOLAMIDE E It is a sulfonamide derivative. It is a sulfonamide derivative. noncompetitively but reversible inhibits.
DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Unit.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 25 Diuretics.
DIURETIC DRUGS (DR.Farooq Alam) DIURETIC DRUGS (DR.Farooq Alam)
DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Department.
Prof. Hanan Hagar Pharmacology Department
P. 954 Copyright © 2009 Pearson Education, Inc., publishing as Pearson Benjamin Cummings © 2012 Pearson Education, Inc.
Tambahkanlah Ilmuku dan Berilah aku pengertian dengan baik Tiada sia-sia Meraih Ilmu dan Mengamalkannya.
DIURETICS Diuretics are drugs which increase the excretion of sodium and water from the body by an action on the kidney. Their primary effect is to decrease.
DR. MOHD NAZAM ANSARI.  Some of pathological conditions associated with retention of sodium and water in the body e.g. Congestive Heart failure, Pulmonary.
Vilasinee Hirunpanich B.Pharm(Hon), M.Sc In Pharm (Pharmacology)
Diuretic Agents.
RENAL SYSTEM PHYSIOLOGY
Diuretics and Antihypertensives
DIURETICS How do they work? WHAT DO THEY DO? When do I use them? How do I use them?
Pharmacology – I [PHL 313] DiureticsDiuretics Dr. Hassan Madkhali Assistant Professor Department of Pharmacology E mail:
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 21 Diuretic Agents.
DIURETICS By: Prof. A. Alhaider 1433 H. Anatomy and Physiology of Renal system ► Remember the nephron is the most important part of the kidney which regulates.
Diuretic Agents.
Regulation of Potassium K+
DIURETICS By: Prof. A. Alhaider. Anatomy and Physiology of Renal system ► Remember the nephron is the most important part of the kidney that regulates.
DIURETICS SONG Hui OUTLINE BACKGROUND CLASSIFICATION OF DIURETICS REVIEW AND QUESTIONS.
What is high ceiling diuretic & Why?
Diuretics Clinical Conditions Requiring Diuretic Therapy: Cerebral Edema Cerebral Edema Pulmonary Edema Pulmonary Edema Hypertension Hypertension Congestive.
Diuretics (Saluretics). Diuretics increase urine excretion mainly by ↓ reabsorption of salts and water from kidney tubules These agents are ion transport.
MCQs from High yield areas of Diuretic Pharmacology
Diuretic Agents. Carbonic Anhydrase Inhibitors.
Osmotic diuretics Osmotic diuretics are pharmacologically inert substances (e.g. mannitol ) that are filtered in the glomerulus but not reabsorbed by the.
Tubular Reabsorption and regulation of tubular reabsorption Tortora Ebaa M Alzayadneh, PhD.
Diuretics Blake Briggs, Class of 2017.
Renal mechanisms for control ECF
Sodium Channel Inhibitors
(Furosemide, Ethacrynic acid, Bumetanide and Torsemide) DIURETICS: LOOP DIURETICS (Furosemide, Ethacrynic acid, Bumetanide and Torsemide)
Domina Petric, MD Aquaretics.
Diuretics By S.Bohlooli, PhD.
Diuretic Drugs.
Ass. Prof. Dr. Naza M. Ali Lec G2 19 May 2019 G1 22 May 2019
Presentation transcript:

Diuretic Agents in Hypertension and other disorders Dr. Thomas Abraham PHAR 417: Fall 2004

Diuretic Agents in Hypertension Overview of renal function Filtration of blood in the glomerulus results in significant portion of plasma water being secreted into the proximal convoluted tubules. Much of the bicarbonate, water, glucose and Na+ (65%) are reabsorbed back into circulation from here. Concentration of urine occurs in the Loop of Henle when water is reabsorbed. This is also the site for major reabsorption of Na+ (25%), K+, and Cl -. Calcium and Mg2+ are reabsorbed here as well and under the influence of PTH more Ca2+ is reabsorbed in distal convoluted tubule. Na/K/Cl symporter located in the thick ascending limb of the loop. Further Na+ and Cl- reabsorption is under the control of aldosterone in the collecting tubules while final water reabsorption in the collecting ducts is controlled by ADH.

Diuretic Agents in Hypertension Thiazide Diuretics Thiazides have oral bioavailability and are secreted by the organic acid transporter in the proximal tubule to reach their active site: the distal convoluted tubule Thiazides interfere with Na+/Cl- symporter to decrease NaCl reabsorption in the DCT and may also decrease NaCl reabsorption from late PCT.   Thiazides may compete with Cl- binding to the symporter. Loss of NaCl in the urine results in decreased water reabsoption and a diuresis.

Diuretic Agents in Hypertension Effects of thiazides on urinary excretion Ø      Less effective than loop diuretics since most of the Na+ has been reabsorbed prior to reaching the DCT.    Ø      Has some activity on carbonic anhydrase and can lead to increased bicarbonate and phosphate elimination.     Ø      Increased elimination of Na+ in the DCT leads to K+ wasting and hypokalemia may result; chronic thiazide enhances Ca2+ reabsorption in the DCT possibly by a Na+/Ca2+ exchanger process. Adverse effects related to thiazide diuretics Ø      Extracellular volume depletion, hypokalemia, hypotension, hypercalcemia, hyperurecemia.  Ø      Decrease glucose tolerance, increase plasma LDL levels, allergic reaction in pts. allergic to sulfonamides.

Diuretic Agents in Hypertension Significant Drug Interactions Ø      Decrease efficacy of anticoagulants, sulfonylurea hypoglycemics, insulin; enhance effects of cardiac glycosides, lithium, loop diuretics and vitamin D.     Ø      NSAIDS, bile acid sequestrants and methenamine decrease thiazide efficacy.   Ø      Thiazides may potentiate quinidine-induced ventricular arrhythmias due to the resulting hypokalemia.  Therapeutic Uses 1. Hypertension (alone or in combination); thiazides appear to have additional effects as vasodilators Edema due to CHF, liver failure. Renal stones and failure Nephrogenic diabetes insipidus esp. due to lithium treatment

Diuretic Agents in Hypertension LOOP DIURETICS Ø      Selectively inhibit NaCl reabsorption in the thick ascending portion of the loop of Henle. The high capacity of the NaCl reabsorption process results in these diuretic being the most efficacious (also referred to as high ceiling diuretic). These agents have rapid absorption from the GI tract with torsemide (Demadex®) having the greatest oral bioavailability. These agents are cleared by filtration and secretion by the organic acid transporter and work on the luminal side of the ascending loop.

Diuretic Agents in Hypertension LOOP DIURETICS (cont) Ø      These drugs inhibit the actions of the Na+/K+/2Cl- transport system of the ascending limb of the loop of Henle. The potassium-derived positive potential in the lumen normally drives Ca2+/Mg2+ reabsorption. Loss in this potential results in increased elimination of Ca2+ and Mg2+ ions. Active reabsorption of Ca2+ in the DCT prevents severe hypocalcemia but hypomagnesemia can result. Loop diuretic may have effects to alter blood flow to various vascular beds e.g. renal, venous, that appear independent of the diuretic actions.

Diuretic Agents in Hypertension Ø      Loop diuretic used when rapid and large diuresis is required: acute pulmonary edema, heart failure, hypertension, hypercalcemia, hyperkalemia, acute renal failure. Ø      Large sodium loss in the ascending loop results in increased K+ and H+ loss in the collecting ducts to cause hypokalemia and metabolic alkalosis. This exchange of Na+ for K+ is also regulated by aldosterone thus the actions of loop agents in the ascending limb of the loop of Henle coupled with aldosterone effects in the collecting ducts leads to significant K+ wasting. This can precipitate arrhythmias and in patients on digoxin: potentiate the effects of the cardiac glycoside.    Ø      Other toxicities include: ototoxicity (additive with other agents like aminoglycosides, cisplatin), hyperuricemia, allergic reactions, dehydration.   Allergic sensitivities to furosemide, bumetanide and torsemide may occur in patients with sulfonamide (sulfa antibiotics, hypoglycemics) allergies.

Diuretic Agents in Hypertension Potassium-sparing Diuretics Ø      These agents antagonize the process of Na+ reabsorption at the cortical collecting tubule at the expense of K+. The antagonism may occur at the level of the mineralocorticoid receptor (e.g. for spironolactone) or due to inhibition of Na+ transport through its channel (triamterene and amiloride).    Ø      Spironolactone is a competitive antagonist of the aldosterone receptor (competes with aldosterone) with relatively slow onset of action due to extensive hepatic metabolism. Triamterene undergoes hepatic metabolism that decreases its plasma t1/2 while amiloride is cleared in the urine unchanged.

Diuretic Agents in Hypertension Ø      Potassium-sparing diuretics decrease Na+ reabsorption in the collecting tubules and consequently prevent the secretion of K+. Aldosterone enhances Na+/K+-ATPase activity and Na+ and K+ channel activities to increase Na+ reabsoption and thereby increase water reabsorption (figure). This process is inhibited by spironolactone which binds to the cytoplasmic mineralocorticoid receptor to prevent the action of aldosterone. Triamterene and amiloride directly interfere with the Na+ channel to prevent the reabsorption of the ion.    Ø      Other drugs that have K+-sparing activity include NSAIDS, ACE inhibitors, angiotenisin II receptor antagonists and b-adrenoceptor antagonists. Thus K+-sparing diuretic may have additive effects with these agents.  Ø      Significant toxicities include: hyperkalemia, hyperchloremia, gynecomastia, acute renal failure (esp. triamterene + indomethecin), kidney stones.

Diuretic Agents in Hypertension Eplerenone (Inspra®) Aldosterone as part of the RAAS causes increased Na+/water retention and hypertension. Aldosterone may have additional mechanisms to elevated systemic blood pressure. Eplerenone binds to mineralocorticoid receptors in renal and other tissues to decrease Na/water retention and decrease BP. Eplerenone may be used alone or in combination with other agents (ACEI and ARBs) to control BP.

Diuretic Agents in Hypertension Osmotic Diuretics Ø      Mannitol is the most commonly used of these agents. Primarily used to reduce intracranial pressure during stroke or hemorrhage or to increase the renal elimination of toxins (e.g. radiocontrast dyes).    Ø      These agents are filtered in the glomerulus but are not reabsorbed from the renal tubules. Being highly polar it increases the osmotic pressure in the renal tubules increasing the the loss of water in regions of the nephron that are freely permeable to water (proximal tubule and descending limb of loop of Henle).   Ø      Mannitol has to be administered parenterally to produce diuresis; oral administration leads to osmotic diarrhea. Ø      Mannitol is used in cases of renal failure, to reduce intracranial pressure, reduce intraocular pressure; not used to treat hypertension. Toxicity associated with use include pulmonary edema, headache, nausea, vomiting and precipitation of heart failure (all primarily due to extracellular volume expansion).

Diuretic Agents in Hypertension Carbonic Anhydrase Inhibitors Ø      Carbonic anhydrase is found in many cell types but concentrated in the luminal membranes of proximal convoluted tubules.   Ø      CA is responsible for the conversion of carbonic acid to bicarbonate to limit bicarbonate elimination in the proximal tubule: Ø      Dehydration of carbonic acid to carbon dioxide and water in the tubular lumen is followed by passive CO2 diffusion back into the proximal tubular cell where it combines with intracellular water to form carbonic acid again.

Diuretic Agents in Hypertension Ø      The cellular carbonic acid dissociates into bicarbonate and hydrogen ions and the H+ becomes available to the tubular Na+/H+ antiporter that pumps in one Na+ ion for every H+ ion it pumps out into the tubular lumen. This allows for the reabsorption of both Na+ and HCO3- ions from the glomerular filtrate and decreases its pH. Ø      Inhibition of carbonic anhydrase by selective inhibitors results in decreased bicarbonate and Na+ reabsorption. This leads to decreased water reabsorption or greater diuresis.